AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28873036 — intervention group
Group type: COMPARATOR
Intervention: Landscape Imagery Observation Physical Training (LIOPT)
Number of subjects: 24
Study 27193270 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 2917
Study 24804842 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (dutasteride + tamsulosin)
Number of subjects: 4722
Study 24804842 — intervention group
Group type: COMPARATOR
Intervention: Dutasteride monotherapy
Number of subjects: 4722
Study 24804842 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin monotherapy
Number of subjects: 4722
Study 23680817 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg/day) plus modular CBT for 16 weeks, followed by maintenance escitalopram for 28 weeks
Number of subjects: 73
Study 23680817 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram alone followed by maintenance escitalopram
Number of subjects: 73
Study 23680817 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram plus CBT followed by pill placebo
Number of subjects: 73
Study 23680817 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram alone followed by placebo
Number of subjects: 73
Study 20614521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecdisten (20 mg daily for 10 days)
Number of subjects: 0
Study 20614521 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 0
Study 18379166 — intervention group
Group type: EXPERIMENTAL
Intervention: Mask A (with exhaust valves)
Number of subjects: 10
Study 18379166 — intervention group
Group type: COMPARATOR
Intervention: Mask B (with exhaust holes)
Number of subjects: 10
Study 16981109 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified ingestion procedure (SIP)
Number of subjects: 24
Study 16981109 — intervention group
Group type: COMPARATOR
Intervention: Original ingestion procedure
Number of subjects: 24
Study 14552094 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of vascular accesses (VA) in European dialysis centres
Number of subjects: 0
Study 14552094 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous vascular accesses and interventions before first use
Number of subjects: 0
Study 14552094 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' role in prevention and management of VA complications
Number of subjects: 0
Study 11216327 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumatic group (TG) with intraoral traumatic factors
Number of subjects: 110
Study 11216327 — intervention group
Group type: COMPARATOR
Intervention: Non-traumatic group (NTG) without intraoral traumatic factors
Number of subjects: 110
Study 9172847 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative teaching with an ICU tour (patients, n = 44; family members, n = 43)
Number of subjects: 183
Study 9172847 — intervention group
Group type: COMPARATOR
Intervention: Preoperative teaching only (control group, patients, n = 48; family members, n = 48)
Number of subjects: 183
Study 8380567 — intervention group
Group type: EXPERIMENTAL
Intervention: 72 Gy hyperfractionated radiation therapy + BCNU (80 mg/m2 on days 3, 4, 5 of radiation therapy and then every 8 weeks for 1 year)
Number of subjects: 435
Study 8380567 — intervention group
Group type: EXPERIMENTAL
Intervention: 81.6 Gy hyperfractionated radiation therapy + BCNU
Number of subjects: 435
Study 8380567 — intervention group
Group type: COMPARATOR
Intervention: Lower radiation dose range (60-74.4 Gy)
Number of subjects: 435
Study 8380567 — intervention group
Group type: COMPARATOR
Intervention: 60 Gy conventional fractionation + BCNU
Number of subjects: 435
Study 3717993 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple, incentive based behaviour modification
Number of subjects: 0
Study 3717993 — intervention group
Group type: EXPERIMENTAL
Intervention: Modest programme of psychotherapy
Number of subjects: 0
Study 3717993 — intervention group
Group type: COMPARATOR
Intervention: Social disadvantage
Number of subjects: 0
Study 3717993 — intervention group
Group type: COMPARATOR
Intervention: Failure to respond to treatment
Number of subjects: 0
Study 3717993 — intervention group
Group type: EXPERIMENTAL
Intervention: Fairly simple programmes
Number of subjects: 0
Study 3717993 — intervention group
Group type: COMPARATOR
Intervention: More elaborate and expensive strategies
Number of subjects: 0
Study 29526378 — intervention group
Group type: EXPERIMENTAL
Intervention: pEVAR
Number of subjects: 50
Study 29526378 — intervention group
Group type: COMPARATOR
Intervention: cEVAR
Number of subjects: 50
Study 26350485 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 50
Study 26350485 — intervention group
Group type: COMPARATOR
Intervention: Saline solution injections (control)
Number of subjects: 50
Study 24938176 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 160/120 (sabal and urtica extracts)
Number of subjects: 922
Study 24938176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 922
Study 24938176 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 922
Study 24938176 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 922
Study 23252453 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin (4 mg twice daily)
Number of subjects: 121
Study 23252453 — intervention group
Group type: COMPARATOR
Intervention: Naftopidil (50 mg once daily)
Number of subjects: 121
Study 23252453 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 121
Study 23252453 — intervention group
Group type: COMPARATOR
Intervention: Naftopidil
Number of subjects: 121
Study 20575258 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-Hib vaccine
Number of subjects: 690
Study 20575258 — intervention group
Group type: COMPARATOR
Intervention: DTaP+Hib separately
Number of subjects: 690
Study 17568589 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 microg/kg/min for 24 hours)
Number of subjects: 26
Study 17083354 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 60
Study 17083354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 14705689 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-body forced-air cover
Number of subjects: 18
Study 14705689 — intervention group
Group type: COMPARATOR
Intervention: Blanket (control)
Number of subjects: 18
Study 12093769 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler strain rate echocardiography
Number of subjects: 58
Study 12093769 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler strain rate echocardiography during dobutamine infusion
Number of subjects: 58
Study 12093769 — intervention group
Group type: COMPARATOR
Intervention: Doppler strain rate echocardiography vs tagged MRI
Number of subjects: 58
Study 12038477 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with mean particle size (MPS) 50 microm
Number of subjects: 47
Study 12038477 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with mean particle size (MPS) 758 microm
Number of subjects: 47
Study 12038477 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with mean particle size (MPS) 692 microm
Number of subjects: 47
Study 12038477 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with mean particle size (MPS) 1158 microm
Number of subjects: 47
Study 12038477 — intervention group
Group type: COMPARATOR
Intervention: Control low fiber bread
Number of subjects: 47
Study 8747670 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine (CHX)
Number of subjects: 40
Study 8747670 — intervention group
Group type: EXPERIMENTAL
Intervention: Meridol (amine fluoride/stannous fluoride solution)
Number of subjects: 40
Study 8747670 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine (phenolic compound)
Number of subjects: 40
Study 8747670 — intervention group
Group type: COMPARATOR
Intervention: Control solution (0.02% quinine-hydrochloride)
Number of subjects: 40
Study 1776404 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin replacement therapy (B1, B2, B6)
Number of subjects: 16
Study 1776404 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 16
Study 6182343 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive protocol using adriamycin, cyclophosphamide, vincristine, dacarbazine for remission induction; additional randomized group received high dose β‐interferon.
Number of subjects: 140
Study 3931536 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydioxanone suture (PDS)
Number of subjects: 233
Study 3931536 — intervention group
Group type: COMPARATOR
Intervention: Polyamide (Nylon)
Number of subjects: 233
Study 29703286 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin administration every 1 minute during UV-A exposure at 3mW/cm2
Number of subjects: 56
Study 29703286 — intervention group
Group type: COMPARATOR
Intervention: Riboflavin administration every 2 minutes during UV-A exposure at 3mW/cm2
Number of subjects: 56
Study 29703286 — intervention group
Group type: EXPERIMENTAL
Intervention: Transepithelial CXL
Number of subjects: 56
Study 27157034 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) for emotional disorders
Number of subjects: 17
Study 25899750 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopaminergic treatment (ON state)
Number of subjects: 17
Study 25899750 — intervention group
Group type: EXPERIMENTAL
Intervention: ELEVATED plank condition
Number of subjects: 17
Study 25899750 — intervention group
Group type: COMPARATOR
Intervention: GROUND plank condition
Number of subjects: 17
Study 23765186 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 41
Study 23765186 — intervention group
Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 41
Study 20495885 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg)
Number of subjects: 755
Study 20495885 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling (motivational interviewing)
Number of subjects: 755
Study 20495885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 755
Study 20495885 — intervention group
Group type: COMPARATOR
Intervention: Counseling (health education)
Number of subjects: 755
Study 18250350 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT)
Number of subjects: 1067
Study 18250350 — intervention group
Group type: COMPARATOR
Intervention: Control group (no radiotherapy)
Number of subjects: 1067
Study 16700661 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg/day)
Number of subjects: 11
Study 16700661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 14580034 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A injections, dosage 10 to 50 U per site, total dose up to 200 U in the masticatory system, maximum 400 U if other sites included, injection frequency no more than once every 12 weeks.
Number of subjects: 0
Study 14580034 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections for chronic myofascial trigger points in painful muscles without observable involuntary movements.
Number of subjects: 0
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant treatment
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulant or antiplatelet agents
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous thromboembolism
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent atrial fibrillation
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrium dilation
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged 80 years and over
Number of subjects: 302
Study 10734752 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-permanent atrial fibrillation
Number of subjects: 302
Study 9183756 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mm single ablation zone
Number of subjects: 50
Study 9183756 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mm single ablation zone
Number of subjects: 50
Study 9183756 — intervention group
Group type: EXPERIMENTAL
Intervention: Double ablation (multizone)
Number of subjects: 50
Study 9183756 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 50
Study 1534176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (12 mg orally over 24 h)
Number of subjects: 9
Study 1534176 — intervention group
Group type: COMPARATOR
Intervention: Amphetamine (15 mg orally)
Number of subjects: 9
Study 3519482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 0.5 g every 8 hours for at least 5 days
Number of subjects: 197
Study 3519482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 1.0 g every 8 hours for at least 5 days
Number of subjects: 197
Study 29765876 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rPMS treatment
Number of subjects: 26
Study 29765876 — intervention group
Group type: COMPARATOR
Intervention: Sham rPMS treatment
Number of subjects: 26
Study 26658133 — intervention group
Group type: EXPERIMENTAL
Intervention: MRgFUS
Number of subjects: 20
Study 26658133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 24388868 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (BUD/FM; Symbicort(®)) for maintenance and reliever therapy (SMART group, n=15)
Number of subjects: 30
Study 24388868 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/SM group, n=15)
Number of subjects: 30
Study 22917936 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision mini-sling (Ajust®)
Number of subjects: 137
Study 22917936 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape-obturator (TVT-O™)
Number of subjects: 137
Study 20526776 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolisation (UAE)
Number of subjects: 57
Study 20526776 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 57
Study 18403271 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% mannitol iv in 1 L 0.9% NaCL for 4 hours for 5 consecutive days
Number of subjects: 41
Study 18403271 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCL (placebo)
Number of subjects: 41
Study 16185958 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy with porfimer sodium (PORPDT) plus omeprazole
Number of subjects: 208
Study 16185958 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole only (OM)
Number of subjects: 208
Study 12947533 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing plus elastic compression (Group B)
Number of subjects: 60
Study 12947533 — intervention group
Group type: COMPARATOR
Intervention: Unna boot (Group A)
Number of subjects: 60
Study 10872850 — intervention group
Group type: EXPERIMENTAL
Intervention: Trillium Biopassive Surface (TBS) coated oxygenators
Number of subjects: 139
Study 10872850 — intervention group
Group type: COMPARATOR
Intervention: Conventional circuits
Number of subjects: 139
Study 9182115 — intervention group
Group type: EXPERIMENTAL
Intervention: Netivudine 200 mg twice daily
Number of subjects: 0
Study 9182115 — intervention group
Group type: EXPERIMENTAL
Intervention: Netivudine (50 mg and 100 mg doses also tested)
Number of subjects: 0
Study 9182115 — intervention group
Group type: EXPERIMENTAL
Intervention: Netivudine (all doses)
Number of subjects: 0
Study 1431261 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (AP)
Number of subjects: 72
Study 1431261 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular diphtheria and tetanus toxoids pertussis vaccine (ADTP)
Number of subjects: 72
Study 1431261 — intervention group
Group type: COMPARATOR
Intervention: Whole cell DTP
Number of subjects: 72
Study 1431261 — intervention group
Group type: EXPERIMENTAL
Intervention: ADTP
Number of subjects: 72
Study 1431261 — intervention group
Group type: COMPARATOR
Intervention: DTP
Number of subjects: 72
Study 6715565 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac (150 and 200 mg, b.i.d.)
Number of subjects: 60
Study 6715565 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (250 and 375 mg, b.i.d.)
Number of subjects: 60
Study 6715565 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (650 and 975 mg, q.i.d.)
Number of subjects: 60
Study 6715565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29668399 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 20
Study 29668399 — intervention group
Group type: COMPARATOR
Intervention: Complementary and Alternative Medicine (CAM)
Number of subjects: 20
Study 28418767 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship care nurse counseling session coupled with individualized treatment summaries and survivorship care plans
Number of subjects: 212
Study 28418767 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 25044819 — intervention group
Group type: EXPERIMENTAL
Intervention: One visit intervention (face-to-face home visit plus telephone calls)
Number of subjects: 148
Study 25044819 — intervention group
Group type: EXPERIMENTAL
Intervention: Two visit intervention
Number of subjects: 148
Study 25044819 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 148
Study 22979994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric BP-I disorder comorbid with ADHD
Number of subjects: 239
Study 22979994 — intervention group
Group type: COMPARATOR
Intervention: Non-bipolar ADHD
Number of subjects: 239
Study 22979994 — intervention group
Group type: COMPARATOR
Intervention: Control children with neither ADHD nor BP-I disorder
Number of subjects: 239
Study 21561956 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg l-amphetamine
Number of subjects: 136
Study 21561956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 18442722 — intervention group
Group type: EXPERIMENTAL
Intervention: RATG induction therapy
Number of subjects: 44
Study 18442722 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional immunosuppression)
Number of subjects: 44
Study 17181618 — intervention group
Group type: EXPERIMENTAL
Intervention: Millennium Custom Control Software (CCS)
Number of subjects: 0
Study 17181618 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 0
Study 12889553 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 247
Study 12889553 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-aspirin NSAIDs
Number of subjects: 247
Study 11126262 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 45
Study 11126262 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 45
Study 9015602 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled studies
Number of subjects: 282
Study 1317643 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-mg PGE2 vaginal suppository
Number of subjects: 267
Study 1317643 — intervention group
Group type: COMPARATOR
Intervention: 3-mg PGE2 vaginal tablet
Number of subjects: 267
Study 6512894 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine exploration for all injuries to the neck violating the platysma muscle (Group A)
Number of subjects: 160
Study 6512894 — intervention group
Group type: COMPARATOR
Intervention: Selective management based on clinical or radiographic evidence of major vascular, visceral, or airway injury (Group B)
Number of subjects: 160
Study 30303628 — intervention group
Group type: EXPERIMENTAL
Intervention: Tylerdipine after a high-fat meal
Number of subjects: 14
Study 30303628 — intervention group
Group type: COMPARATOR
Intervention: Fasting state
Number of subjects: 14
Study 29117072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent standing (4 h of sitting interrupted with four 10‐min bouts of standing)
Number of subjects: 13
Study 29117072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent desk pedaling (4 h of sitting interrupted with four 10‐min bouts of light-intensity desk pedaling)
Number of subjects: 13
Study 29117072 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (4 h of uninterrupted sitting)
Number of subjects: 13
Study 27260500 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postnatal care three days after delivery provided in-person with a CHW using a simple checklist
Number of subjects: 0
Study 27260500 — intervention group
Group type: EXPERIMENTAL
Intervention: Care provided by phone with a CHW using the same checklist
Number of subjects: 0
Study 27260500 — intervention group
Group type: COMPARATOR
Intervention: Standard of care group
Number of subjects: 0
Study 25056813 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support program
Number of subjects: 0
Study 25056813 — intervention group
Group type: COMPARATOR
Intervention: Control care
Number of subjects: 0
Study 22412170 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the unaffected hemisphere
Number of subjects: 27
Study 22412170 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the affected hemisphere
Number of subjects: 27
Study 22412170 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rTMS and tDCS
Number of subjects: 27
Study 22412170 — intervention group
Group type: COMPARATOR
Intervention: Control (1 Hz rTMS only)
Number of subjects: 27
Study 19254210 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day (n=17)
Number of subjects: 30
Study 19254210 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg/day (n=13)
Number of subjects: 30
Study 17593772 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 36
Study 17593772 — intervention group
Group type: COMPARATOR
Intervention: ID
Number of subjects: 36
Study 15337403 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 882
Study 15337403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 882
Study 11772251 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 0
Study 11772251 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 0
Study 11772251 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0